Oppenheimer Raises Target on Alexion (ALXN) to $100 as Asfotase Alfa Data Looks Promising

Go back to Oppenheimer Raises Target on Alexion (ALXN) to $100 as Asfotase Alfa Data Looks Promising
Alexion Pharmaceuticals (NASDAQ: ALXN) Delayed: 182.01 --0 (-0%)
Previous Close $182.01    52 Week High $193.45 
Open $33.31    52 Week Low $110.56 
Day High $182.01    P/E 143.31 
Day Low $182.01    EPS $1.27 
Volume 71